Zicam Swab Platform Takes Center Stage In Matrixx Growth Plans
This article was originally published in The Tan Sheet
Executive Summary
Matrixx Initiatives plans to introduce more products delivered via the swab platform used in one of the Zicam nasal products that FDA advised the firm to recall in 2009
You may also be interested in...
Government Weighs In For Shareholders In Matrixx Supreme Court Case
The federal government says materiality should be the standard for deciding when firms must disclose information about problems to shareholders, arguing that Matrixx Initiatives presents a "false choice" between disclosing all information or only that considered statistically significant.
Government Weighs In For Shareholders In Matrixx Supreme Court Case
The federal government says materiality should be the standard for deciding when firms must disclose information about problems to shareholders, arguing that Matrixx Initiatives presents a "false choice" between disclosing all information or only that considered statistically significant.
Government Weighs In For Shareholders In Matrixx Supreme Court Case
The federal government says materiality should be the standard for deciding when firms must disclose information about problems to shareholders, arguing that Matrixx Initiatives presents a "false choice" between disclosing all information or only that considered statistically significant.